Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine
- Scopolamine Patch Withdrawal Syndrome. Lau, Steve H.; VanEaton, Chris // Hospital Pharmacy;Mar2014, Vol. 49 Issue 3, p218
A letter to the editor is presented which discusses withdrawal symptoms associated with the discontinuation of scopolamine drug used for the control of motion sickness.
- Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Hill, Anabel L.; Roe, Denise J.; Taren, Douglas L.; Muramoto, Myra M.; Leischow, Scott J. // Nicotine & Tobacco Research;Aug2000, Vol. 2 Issue 3, p247
This study examined nicotine replacement effects and pre-quit smoking characteristics with respect to postcessation weight gain in a primarily Mexican-American sample of Hispanic smokers. Hispanic smokers (108) were randomly assigned to receive either nicotine transdermal patch or placebo patch...
- Off-Vertical Axis Rotational Assessment of Transdermal Scopolamine for Motion Sickness Prophylaxis. Woodard, Daniel; Knox, Glenn; Wood, Scott; DiBiase, Cathy // Gravitational & Space Biology;Dec2014, Vol. 2 Issue 2, p13
The objectives of this study were to evaluate transdermal scopolamine for motion sickness prophylaxis, and to evaluate off-vertical axis rotation (OVAR) as a laboratory model of motion sickness. This was a randomized, prospective, double-blind study design, set in a vestibular research...
- NiQuitin CQ Clear 21mg, 14mg, 7mg. // Royal Society of Medicine: Medicines;2002, p394
This article presents information on the drug NiQuitin CQ Clear, which is a proprietary, non-prescription preparation of nicotine. It can be used to cure the withdrawal symptoms experienced when giving up smoking tobacco. It is available as clear transdermal patches in three strengths. It is...
- NiQuitin CQ. // Royal Society of Medicine: Medicines;2002, p394
This article presents information on the drug Niquitin CQ, which is a proprietary, non-prescription preparation of nicotine. It can be used to cure the withdrawal symptoms experienced when giving up smoking tobacco products. It is available in the form of pinkish and clear skin patches for...
- Transdermal Scopolamine for Prevention of Motion Sickness: Clinical Pharmacokinetics and Therapeutic Applications. Nachum, Zohar; Shupak, Avi; Gordon, Carlos R // Clinical Pharmacokinetics;2006, Vol. 45 Issue 6, p543
A transdermal therapeutic system for scopolamine (TTS-S) was developed to counter the adverse effects and short duration of action that has restricted the usefulness of scopolamine when administered orally or parenterally. The plaster contains a reservoir of 1.5mg of scopolamine programmed to...
- Scopolamine Transdermal Patch. // AHFS Consumer Medication Information;Oct2016, p1
Scopolamine is used to prevent nausea and vomiting caused by motion sickness. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
- Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Perkins, Kenneth A.; Lerman, Caryn; Keenan, Jason; Fonte, Carolyn; Coddington, Sarah // Nicotine & Tobacco Research;Jun2004, Vol. 6 Issue 3, p501
The subjective and reinforcing effects of drugs of abuse may depend partly on their rate of onset, with faster acting formulations typically producing stronger effects than slower ones. In this within-subjects study, we examined the acute effects of nicotine replacement therapy via nicotine...
- Nicotinell TTS. // Royal Society of Medicine: Medicines;2002, p392
This article presents information on Nicotinell TTS. It is a proprietary non-prescription preparation of nicotine. It can be used to alleviate the withdrawal symptoms experienced when giving up smoking. It is available in the form of a skin patch for transdermal delivery.